Kaneka Corporation logo

Kaneka Corporation

4118.T

JPXBasic MaterialsChemicals - Specialty

Latest quote

¥6,183

−¥2.00 · -0.03%

Aug 24, 3:30 PM JST

4118.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Kaneka Corporation, established in Tokyo, Japan, in 1949, operates internationally as a diversified manufacturer providing a wide array of advanced materials and specialized products. Its core chemical business includes the production and global distribution of various polyvinyl chloride (PVC) formulations, such as crosslinked, paste, and chlorinated PVC, alongside acryl grafted-vinyl chloride copolymers. The company also supplies critical additives like impact modifiers, processing aids, specialty additives, and tougheners for thermosetting resins. Furthermore, their portfolio features advanced polymers including silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, biodegradable polymers, and engineering resins designed for injection molding, in addition to zero birefringence materials, acrylic films, and isobutylene-based thermoplastic elastomers. Beyond chemicals, Kaneka manufactures specialized foams and films, encompassing polypropylene and Kanelite foams, extruded polystyrene insulation, polyimide films, and transparent films for optical applications. Their material science expertise extends to high thermal conductive graphite sheets, multi-layer insulation, transparent conductive films, and transparent resins engineered for exceptional heat and light resistance. In the energy and innovative products sector, Kaneka offers photovoltaic power generation systems suitable for residential, public, and industrial installations. Other cutting-edge developments include eco-friendly fur, flame-retardant materials, hair accessories, novel materials, organic EL lighting panels, and biosurfactants. Their life sciences division delivers a comprehensive range of medical and pharmaceutical offerings, which include intervention and blood purification systems, gastroenterology intervention tools, diagnostic testing equipment, regenerative medicine and cell therapy solutions, and genetic diagnostics. Additionally, they provide low molecular pharmaceutical raw materials, affinity chromatography resins for monoclonal antibody purification, biopharmaceuticals, transdermal medicines, and innovative shock-absorbing innerwear. Lastly, Kaneka is a significant player in the food and nutrition industry. Their extensive product line features dairy products, margarines, fats and oils, whipping creams, fillings, baking essentials (baker's yeast, dough improvers), processed fruits, butter, shortening, cacao butter alternatives, various creams, frozen dough, spices, and antifreeze materials. They also supply pharmaceutical and supplemental nutrition solutions, such as coenzyme Q10, lactic-acid bacteria, and functional foodstuffs, alongside agricultural fertilizers.

Industry
Chemicals - Specialty
Sector
Basic Materials
Headquarters
JP
CEO
Kazuhiko Fujii
Listed since
Jan 1, 2001
Employees
11,762

Market position

Volume
207.1K
0.84× average
Average volume
246.51K
Average daily volume
Market cap
372.37B JPY
Beta
0.32
Market reference 1

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
476.67B JPY
P/E (TTM)
10.6×
P/B (TTM)
0.74×
P/S (TTM)
0.45×
EV / EBITDA
4.95×
Earnings yield
10.45%
Free cash flow yield
0.46%
Dividend yield
2.59%

Profitability & efficiency

Gross margin
28.19%
Operating margin
4.60%
Net margin
4.27%
Return on equity
6.20%
Return on assets
3.23%
Return on invested capital
2.89%

Financial health

Debt / equity
0.45×
Current ratio
1.53×
Altman Z-score
2.24
Piotroski F-score
5 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends30%20%10%1%Gross margin, FY2022: 27.54%Gross margin, FY2023: 25.20%Gross margin, FY2024: 25.61%Gross margin, FY2025: 26.79%Gross margin, FY2026: 27.63%Operating margin, FY2022: 6.30%Operating margin, FY2023: 4.49%Operating margin, FY2024: 4.12%Operating margin, FY2025: 4.84%Operating margin, FY2026: 3.90%Net margin, FY2022: 3.83%Net margin, FY2023: 3.04%Net margin, FY2024: 3.05%Net margin, FY2025: 3.14%Net margin, FY2026: 3.82%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 27.54%. Gross margin FY2023 25.20%. Gross margin FY2024 25.61%. Gross margin FY2025 26.79%. Gross margin FY2026 27.63%. Operating margin FY2022 6.30%. Operating margin FY2023 4.49%. Operating margin FY2024 4.12%. Operating margin FY2025 4.84%. Operating margin FY2026 3.90%. Net margin FY2022 3.83%. Net margin FY2023 3.04%. Net margin FY2024 3.05%. Net margin FY2025 3.14%. Net margin FY2026 3.82%.

Income trends

Revenue

811.64B JPY+0.55%

Operating income

31.64B JPY-18.96%

Net income

30.98B JPY+22.40%
Income trends across reported periods890.5B JPY575.05B JPY259.6B JPY−55.86B JPYRevenue, FY2022: 691.53B JPYRevenue, FY2023: 755.82B JPYRevenue, FY2024: 762.3B JPYRevenue, FY2025: 807.2B JPYRevenue, FY2026: 811.64B JPYOperating income, FY2022: 43.56B JPYOperating income, FY2023: 33.94B JPYOperating income, FY2024: 31.41B JPYOperating income, FY2025: 39.04B JPYOperating income, FY2026: 31.64B JPYNet income, FY2022: 26.49B JPYNet income, FY2023: 23.01B JPYNet income, FY2024: 23.22B JPYNet income, FY2025: 25.31B JPYNet income, FY2026: 30.98B JPYFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 691.53B JPY. Revenue FY2023 755.82B JPY. Revenue FY2024 762.3B JPY. Revenue FY2025 807.2B JPY. Revenue FY2026 811.64B JPY. Operating income FY2022 43.56B JPY. Operating income FY2023 33.94B JPY. Operating income FY2024 31.41B JPY. Operating income FY2025 39.04B JPY. Operating income FY2026 31.64B JPY. Net income FY2022 26.49B JPY. Net income FY2023 23.01B JPY. Net income FY2024 23.22B JPY. Net income FY2025 25.31B JPY. Net income FY2026 30.98B JPY.
Metric (JPY)FY2026FY2025FY2024FY2023FY2022
Revenue811.64B JPY807.2B JPY762.3B JPY755.82B JPY691.53B JPY
Cost of goods sold587.35B JPY590.98B JPY567.1B JPY565.35B JPY501.1B JPY
Gross profit224.29B JPY216.23B JPY195.2B JPY190.47B JPY190.43B JPY
Research and development39.34B JPY35.4B JPY32.67B JPY30.89B JPY
Selling, general, and administrative192.66B JPY137.85B JPY128.4B JPY123.86B JPY115.97B JPY
Operating expenses192.66B JPY177.19B JPY163.8B JPY156.53B JPY146.87B JPY
Interest income275M JPY295M JPY224M JPY222M JPY178M JPY
Interest expense4.09B JPY4.03B JPY3.36B JPY1.97B JPY1.06B JPY
Depreciation and amortization47.43B JPY44.66B JPY41.45B JPY40.11B JPY38.51B JPY
Operating income31.64B JPY39.04B JPY31.41B JPY33.94B JPY43.56B JPY
Net income30.98B JPY25.31B JPY23.22B JPY23.01B JPY26.49B JPY

Company facts updated Aug 24, 2026.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥150

2025 complete year+50.0% since 2021

2026 partial: ¥80.00

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Sep 29, 2026

¥105

Semi-Annual

Record Sep 30, 2026 · Payment Sep 29, 2026

DividendUpcoming

Ex-dividend Mar 30, 2027

¥105

Semi-Annual

Record Mar 31, 2027 · Payment Mar 30, 2027

Dividend

Ex-dividend Mar 30, 2026

¥80.00

Semi-Annual

Record Mar 31, 2026 · Payment Jun 5, 2026

Dividend

Ex-dividend Sep 29, 2025

¥80.00

Semi-Annual

Record Sep 30, 2025 · Payment Dec 5, 2025

Dividend

Ex-dividend Mar 28, 2025

¥70.00

Semi-Annual

Record Mar 31, 2025 · Payment Jun 6, 2025

Dividend

Ex-dividend Sep 27, 2024

¥60.00

Semi-Annual

Record Sep 30, 2024 · Payment Dec 5, 2024

4118.T peers

Continue in GoAI

Research 4118.T

research.disclaimer